Find the latest pharmaceutical market place for APIs enquiry about Nintedanib Esylate on PharmaCompass.com.

turkeypng-1602828403png-1622460951png-1622462103 Flag

Nintedanib Esylate (64 kg) API needed in Turkey [ENA21604]

A company that focuses on development and manufacturing of various finished formulations is looking for suppliers of Nintedanib Esylate (64 kg) API for both development & commercial purposes. The suppliers must support this enquiry with CEP, DMF, GMP & CoA.

Reply

31 Dec 2024

india-flag Flag

Nintedanib Esylate (10 kg) API needed in India [ENA21571]

A company that focuses on manufacturing of soft gel capsules is looking for suppliers of Nintedanib Esylate (10 kg) API for commercial purposes. The suppliers must support this enquiry with CoA.

Reply

27 Dec 2024

Nintedanib Esylate (100 g) API needed in Indonesia [ENA17023]

A pharmaceutical company based in South Korea that focuses on research, development, manufacturing and commercialization of biologics, chemicals, OTC drugs & medical devices is looking for suppliers of Nintedanib Esylate (100 g) API for development purposes. The suppliers must support this enquiry with CoA.

Reply

03 May 2023

NewZealand Flag

Various APIs needed in New Zealand [ENA11993]

A research-based organization that specializes in pre-formulation assessments, stable, scalable, robust and efficient technology transfer processes is looking for suppliers of Various APIs for development purpose.
1. Trabectedin API
2. Pirfenidone API
3. Nintedanib API

Reply

02 Dec 2021

United_States_of_America Flag

Nintedanib API needed in the US [ENA06674]

A late-stage clinical biopharmaceutical company focused on the development and commercialization of therapeutics is looking for suppliers of free base Nintedanib API. The suppliers must support this enquiry with valid USDMF.

Reply

26 Feb 2020

Enquiry//Captopril & Nintedanib Esylate for filing in the United States [EN00419]

A specialty pharmaceutical company in India, engaged in development, manufacture and marketing of quality finished dosages with more than 6,000 employees and revenues in excess of USD 200 million is searching for Captopril & Nintedanib Esylate for the US Market.
They are searching for a reliable partner to support their filings.

Reply

17 Jun 2016